Proportion of positive cells and MFI
. | BM Control . | BM Ptx* . | Blood Control . | Blood Ptx* . |
|---|---|---|---|---|
| Mice | ||||
| c-kit (CD117) | 36.8 (230) | 38.1 (264) | 6.0 (111) | 16.3 (253) |
| L-selectin (CD62L) | 77.4 (156) | 75.9 (139) | 61.3 (72) | 58.3 (49) |
| Integrin αIIb (CD41) | 15.9 (199) | 10.4 (192) | 50.2 (862) | 42.3 (392) |
| TER-119 (Ly-76) | 22.1 (3363) | 34.4 (3324) | 5.6 (2972) | 4.2 (944) |
| CXCR4 (CD184) | 52.9 (53) | 61.4 (58) | 19.2 (63) | 66.0 (55) |
| Monkey | ||||
| LFA-1 (CD11a) | 41.6 (380) | 59.8 (473) | 77.0 (1916) | 98.2 (439) |
| PECAM-1 (CD31) | 37.3 (218) | 49.3 (245) | 50.9 (371) | 83.6 (281) |
| CD34 | 16.2 (150) | 5.8 (43) | 1.6 (85) | 5.9 (49) |
. | BM Control . | BM Ptx* . | Blood Control . | Blood Ptx* . |
|---|---|---|---|---|
| Mice | ||||
| c-kit (CD117) | 36.8 (230) | 38.1 (264) | 6.0 (111) | 16.3 (253) |
| L-selectin (CD62L) | 77.4 (156) | 75.9 (139) | 61.3 (72) | 58.3 (49) |
| Integrin αIIb (CD41) | 15.9 (199) | 10.4 (192) | 50.2 (862) | 42.3 (392) |
| TER-119 (Ly-76) | 22.1 (3363) | 34.4 (3324) | 5.6 (2972) | 4.2 (944) |
| CXCR4 (CD184) | 52.9 (53) | 61.4 (58) | 19.2 (63) | 66.0 (55) |
| Monkey | ||||
| LFA-1 (CD11a) | 41.6 (380) | 59.8 (473) | 77.0 (1916) | 98.2 (439) |
| PECAM-1 (CD31) | 37.3 (218) | 49.3 (245) | 50.9 (371) | 83.6 (281) |
| CD34 | 16.2 (150) | 5.8 (43) | 1.6 (85) | 5.9 (49) |
All entries are percentages, followed by MFI in parentheses.
Ptx-treated mice were each injected intravenously with 100 ng of the toxin 3 days earlier. The monkey was injected with 25 μg/kg Ptx.